Medicare Enrolled

Dr. Lauren Pankratz, M.D.

Pediatric Endocrinology · San Antonio, TX
5107 MEDICAL DR, San Antonio, TX 78229
2106148612
Registered in NPPES since 2007
NPI: 1568675726 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pankratz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pankratz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pankratz

Dr. Lauren Pankratz is a pediatric endocrinology specialist in San Antonio, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Pankratz received a total of $18,438 from 61 pharmaceutical and/or device companies across 784 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pankratz is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $18,438 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$18,438
Total received (2018-2024)
Avg $2,634/year across 7 years
Top 15% in TX for pediatric endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
784
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,119
2023
$2,067
2022
$2,193
2021
$1,629
2020
$1,399
2019
$3,669
2018
$5,362

Payments by company (2024)

Novo Nordisk Inc
$311
ABBVIE INC.
$190
Tolmar, Inc.
$160
Medtronic, Inc.
$153
Neurocrine Biosciences, Inc.
$151
SANOFI-AVENTIS U.S. LLC
$144
Ascendis Pharma Inc
$141
Insulet Corporation
$139
Eton Pharmaceuticals, Inc.
$92
Abbott Laboratories
$87
Azurity Pharmaceuticals, Inc.
$81
Amphastar Pharmaceuticals, Inc.
$72
Tandem Diabetes Care, Inc.
$60
Ascensia Diabetes Care Us Inc.
$58
PFIZER INC.
$58
RECORDATI_RARE_DISEASES_INC.
$44
Kyowa Kirin, Inc.
$40
Mannkind Corporation
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Dexcom, Inc.
$20
Amgen Inc.
$20
Alexion Pharmaceuticals, Inc.
$17
Xeris Pharmaceuticals, Inc.
$16
Endo USA, Inc.
$14
Top 3 companies account for 31.2% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$2,991
Tandem Diabetes Care, Inc.
$2,953
Novo Nordisk Inc
$1,693
Insulet Corporation
$997
Lilly USA, LLC
$929
Abbott Laboratories
$658
Medtronic, Inc.
$545
ABBVIE INC.
$463
TOLMAR Pharmaceuticals, Inc.
$404
Ascendis Pharma Inc
$387
Xeris Pharmaceuticals, Inc.
$367
PFIZER INC.
$361
Tolmar, Inc.
$319
Medtronic MiniMed, Inc.
$317
Ferring Pharmaceuticals Inc.
$316
Alexion Pharmaceuticals, Inc.
$310
ARBOR PHARMACEUTICALS, INC.
$307
Ultragenyx Pharmaceutical Inc.
$300
AbbVie Inc.
$261
Zealand Pharma US, Inc.
$245
Mannkind Corporation
$222
Azurity Pharmaceuticals, Inc.
$208
Eton Pharmaceuticals, Inc.
$204
BioMarin Pharmaceutical Inc.
$193
Endo Pharmaceuticals Inc.
$180
Dexcom, Inc.
$159
Neurocrine Biosciences, Inc.
$151
VistaPharm, Inc.
$148
SANOFI-AVENTIS U.S. LLC
$144
Becton, Dickinson and Company
$143
Ascendis Pharma, Inc.
$142
MannKind Corporation
$139
AstraZeneca Pharmaceuticals LP
$121
Sandoz Inc.
$99
Kyowa Kirin, Inc.
$84
Companion Medical, Inc.
$84
Rhythm Pharmaceuticals, Inc.
$83
Ascensia Diabetes Care Us Inc.
$82
Arbor Pharmaceuticals, Inc.
$82
Organogenesis Inc.
$79
Valeritas, Inc.
$73
Amphastar Pharmaceuticals, Inc.
$72
RECORDATI_RARE_DISEASES_INC.
$61
IBSA Pharma Inc.
$54
Nalpropion Pharmaceuticals, Inc.
$29
Orexigen Therapeutics, Inc.
$26
Merck Sharp & Dohme LLC
$25
Corcept Therapeutics
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Amgen Inc.
$20
Esperion Therapeutics, Inc.
$19
Ipsen Biopharmaceuticals, Inc
$19
Nevro Corp.
$16
Antares Pharma, Inc.
$16
LifeScan, Inc.
$15
DEXCOM, INC.
$15
Endo USA, Inc.
$14
Strongbridge US INC.
$14
Radius Health, Inc.
$12
AKRIMAX PHARMACEUTICALS, LLC
$12
Janssen Pharmaceuticals, Inc
$8
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ALKINDI · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CONTRAVE · CREON · Creon · Crysvita · Cryvista · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · Dojolvi · ELIGARD · EUCRISA · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FENSOLVI · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GENOTROPIN · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · Gliadel · HUMALOG · HUMATROPE · HUMULIN · HUMULIN R 500 · INCRELEX · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · Imcivree · InPen · JARDIANCE · Kanuma · Korlym · LUPRON DEPOT · LYUMJEV · Lupron · Lupron Depot · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · Macrilen · Minimed 630G · Minimed 670G System · Minimed 770G System · NASCOBAL · NEXLIZET · NGENLA · NOCDURNA · Norditropin · OMNITROPE · Omnia · Omnipod · OneTouch · Ozempic · Proclaim Family of SCS IPGs · Puraply · Rybelsus · SIGNIFOR LAR · SKYTROFA · STEGLUJAN · SUPPRELIN · SUPPRELIN LA · SYNTHROID · Saxenda · Skytrofa · Sogroya · Strensiq · Synthroid · TEPEZZA · TRADJENTA · TRIPTODUR · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Triptodur · Tymlos · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VANTA ADAPTIVESTIM · VIVIMUSTA · Victoza · Wegovy · XARELTO · ZEGALOGUE · ZOMACTON · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric endocrinology specialist in San Antonio?
Compare pediatric endocrinologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologists nearby

Geographic Context

Pediatric endocrinologists in nearby ZIP areas
11
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pankratz is a pediatric endocrinology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Pankratz receive payments from pharmaceutical companies?
Yes. Dr. Pankratz received a total of $18,438 from 61 companies across 784 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Pankratz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →